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Summary and Key Points 
1. Pathology is the study and diagnosis of disease. 
2. Cancer is generally defined as a malignant process of autonomous, 
unregulated cell proliferation with the ability to spread (metastasize) 
to distant sites. 
3. Cancers are usually named based on the organ from which they 
arise; they are many diseases. 
4. Cancer is the second leading cause of death in the United States 
surpassed only by cardiovascular disease. 
5. Cancers frequently develop from precursor lesions. 
6. Surgical pathologists use gross and microscopic study of tissue for 
classification and understanding the pathogenesis of disease. 
Introduction 
Pathology 
The department of pathology is inclusive of clinical pathology 
(microbiology, blood bank, chemistry, and hematology), anatomic 
pathology (autopsy/forensics, cytopathology, and surgical pathology) and 
molecular pathology. Pathologists are responsible for choosing the 
methodology and overseeing the accuracy and precision of the testing 
results reported in lab reports and the stated normal and abnormal ranges. 
Any questions regarding how to obtain a sample, appropriate test to order, 
or interpretation of a test can be directed to a pathologist for guidance; 
since pathologists are considered the “doctor’s doctor.” Cytopathology is 
the subspecialty that reviews the cells in CSF, urines, pap smears, 
brushings and fine needle aspirations of lesions. 
Cytopathologists can provide quick on-site immediate assessment for 
adequacy of sampling of fine needle aspiration biopsies, usually 
performed on an outpatient basis. A surgical pathologist examines and 
interprets biopsies, excisions of organs, and autopsies. Surgical 
pathologists can offer intra-operative frozen section diagnoses to guide 
surgical management. 
Patients and physicians depend on pathologists to make the diagnosis of 
cancer and of the specific type of cancer. Pathologists are expert in pattern 
recognition and in the natural history of diseases, including cancers. 
Cancer 
Cancer is the second leading cause of death in the United States 
surpassed only by cardiovascular disease. Our understanding of how 
cancers begin and spread has undergone a significant change over the 
last half century. Historically, theories invoked to explain the cause of 
cancer included infectious diseases and nutritional deficiencies. While the 
development of some cancers can result from infections, we now 
appreciate that cancers occur as the result of DNA mutations in normal 
cells. 
Basic Principles 
In general, cancer cells are distinguished from normal cells by two 
fundamental properties. First, cancers possess abnormalities in the 
regulation of cell division and survival. Most cells in the human body are 
not actively dividing at any given moment. Entry into cell cycle is tightly 
controlled in normal cells. Many cancers, however, have alterations in one 
or more proteins that regulate mitotic activity. Normal cells also will 
undergo apoptosis – programmed cell death – as a result of a variety of 
conditions including extensive damage to the genome. Cancer cells, 
however, frequently have alterations in the genes that control apoptosis 
and, therefore, survive in conditions that would normally be lethal. 
The second characteristic of cancer cells that distinguishes them from 
normal cells is the ability to metastasize. Metastasis refers to the cancer 
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cells acquired ability to break away from neighboring cells, traverse tissue 
boundaries, enter and travel through lymphatics and blood vessels, and 
then grow in foreign tissue environments. 
It is important to appreciate that cancer is not one disease, but a 
category of many, which share abnormal cell features. The shared 
biologic characteristics of cancerous cells can be classified by their 
required cellular properties defined as follows1: 
1. Ability for a cancer to generate mitogenic signals – this is the ability to 
initiate signal transduction pathways leading to mitosis 
2. Resist exogenous growth-inhibitory signals 
3. Genetic instability- refers to a set of events causing unscheduled 
alteration within the genome. These changes can be broadly divided 
into:  
a) Chromosomal level (i.e. chromosomal gains, loss, 
translocations, duplications etc.) 
b) At the nucleotide level (i.e. mutations in DNA repair pathway, 
mismatch repair pathway defects etc.) 
4. Evade apoptosis and acquire unregulated proliferation (immortalized 
cells) 
5. Angiogenesis (growth and proliferation of blood vessels)– required for 
nutritional support, waste removal and oxygenation to the cancer 
6. Tissue invasion and metastasis through blood or lymphatics 
Many cancers have a pattern of metastasis. For example tumors which 
commonly metastasize to the brain include breast cancer, melanoma, 
renal cell carcinoma (kidney cancer), and lung cancer. In contrast, cancers 
which commonly metastasize to the bone include kidney, thyroid, lung, 
prostate and breast. 
Cell Cycle Regulation 
Normal cells have regulated cell cycles composed of the following phases: 
quiescent phase [G0], growth phase [G1 S, G2] and mitotic phase [M]) 
with checkpoints and a regulated process of programed cell death 
(apoptosis). 
The G1/S checkpoint is involved in most malignancies. This point is 
referred to as the restriction point and is a point of irreversible progression 
towards cell division. Cells will normally continue proliferation in early-mid 
G1, unless inhibited by inhibitory signals or growth factor deprivation. The 
retinoblastoma protein (RB) is a key regulator for irreversible initiation of 
cell division. Inactivation of the RB by phosphorylation allows the cell to 
continue to the S phase. In the event of DNA damage, the ATM (ataxia-
telangiectasia mutated) signal transduction pathway may act to arrest 
replication (G1 or G2 phases) or prolong replication (G1, S, G2 phases) 
for repair of the DNA damage. The ATM pathway phosphorylates MDM2 
bound to p53. The dissociated p53 is now able to stop cell cycle 
progression, synthesize repair enzymes and initiate apoptosis. Apoptosis 
is the process of programmed cell death during cell development or after 
cellular injury. Apoptosis can be readily identified on histologic sections by 
the following features: cell shrinkage, chromatin condensation, formation 
of cytoplasmic blebs, and phagocytizing macrophages. See Robbins and 
Cotran, pp 26-32 for additional details.- The Lamar Souter Library has 
Robbins & Cotran 9th edition, 2015 on the reference shelf; the page 
reference should be 32-60 
Cells with irreparable DNA damage are flagged for apoptosis, thereby 
limiting the potential for uncontrolled cell proliferation. However, in most 
cancers there is one or more genetic alteration in this G1 checkpoint. More 
of these alterations are discussed in the Cancer Biology chapter. 
Pathology: Defining Tumor, Neoplasm and Cancer 
Tumor refers to “swelling” which may produce a mass. The cause of the 
mass may be benign or malignant. It is a generic term that may refer to a 
reactive inflammatory process, an infectious process, benign tissue mass 
or malignant growth of tissue. It is used interchangeably with neoplasm in 
the setting of an abnormal tissue growth (either benign or malignant). 
Neoplasms are derived from a single clone of cells which grow in an 
uncoordinated manner. The term neoplasm refers to a clonal growth which 
can be either benign (non-invasive) or malignant (invasive/cancer). 
Neoplastic cells must undergo a number of genetic alterations in order to 
overcome the regulated cell growth maintained by normal cells. 
Benign neoplasms are localized expansile masses composed of cells with 
unregulated cell growth that, with rare exceptions, do not invade tissues 
and do not metastasize. They often are surrounded by a fibrous capsule 
and usually easy to surgically resect. 
Malignant neoplasms are masses of unregulated cell growth which are 
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locally invasive and can metastasize. Due to their invasive, irregular 
border they can be difficult to surgically resect. The word “cancer”, is 
derived from the Latin word for crab or “karkinos” because of the observed 
finger-like invasion. 
Pathologic examination is performed after a biopsy or surgical removal is 
performed. The evaluation of the cells allows the pathologist to determine 
whether a neoplasm is benign or malignant. Multiple features must be 
evaluated by the pathologist in order to distinguish a benign neoplasm 
from a malignant neoplasm. When a neoplasm is determined malignant, 
the neoplastic borders are assessed for evidence of infiltration and into 
normal tissue. A well differentiated malignancy has features like the tissue 
of origin. However, poorly differentiated malignancies do not appear 
anything like components of the precursor organ, thereby making 
determination of tumor origin more challenging. A low grade (grade 1) 
indicates a well-differentiated malignancy, whereas a high grade (grade 3) 
indicates a poorly differentiated malignancy. The grade of the malignancy 
(differentiation) is a key component of a pathologic assessment. 
Nomenclature 
Cancers are named according to their tissue origin and to describe 
features of the appearance of the malignancy. Medical terminology is 
composed predominantly of Latin prefixes and suffixes which can be 
pieced together to give a description of a neoplasm. A few of the common 
prefixes can be found in the glossary section. 
For example, the prefix (adeno-) means glands and the suffix (– oma) 
means tumor, so an adenoma translates to a benign growth of glands 
(Figure 1). 
In contrast, an adenocarcinoma (adeno meaning glands and carcin 
meaning cancer and oma meaning tumor) is a cancerous growth of glands 
(Figure 2). 
A tumor (-oma) generally suggests a benign growth process, however 
there are exceptions to this rule. For example: Melanoma is a malignant 
neoplasm derived from melanocytes (melan-) residing in the basal layer of 
epithelium. 
Lymphoma is a malignant neoplasm derived from lymphocytes (lymph-). 
Sarcoma– malignant tumor of mesodermal origin (i.e. connective tissue) 
(sarc-, means flesh). 
During embryologic development, pluripotential cells become committed 
into 3 primary lineages: endoderm, mesoderm and ectoderm; these 
continue to differentiate into organs. The endoderm (inner layer) gives rise 
to the digestive tract, respiratory tract, and glands (pancreas and liver etc). 
Mesoderm (middle or mesenchymal layer) differentiates into muscles, 
kidneys, genitals, inner linings (pleura, peritoneum), circulatory system, 
and bones/cartilage. Finally, the ectoderm (outer layer) develops into skin 
and its related structures as well as the central nervous system. 
In routine pathologic classification, cancers are named according to the 
organ/cell from which they originate. Neoplasms can be subdivided based 
into embryologic cell type categories: 
Carcinomas arise from epithelium, both ectoderm and endoderm. 
Benign epithelial neoplasms include papillomas and adenomas (Figure 1) 
Note: The pictures that follow are all hematoxylin and eosin (H&E) 
stained paraffin embedded sections of tissue. Nuclei are typically blue 
and cytoplasm, muscle, etc. pink. Fat appears as circular white spaces 
as shown in Figure 2a & b. 
 
Figures 1a, b. This is a fibroadenoma of the breast composed of a benign 
proliferation of glands within fibrous breast tissue as the name implies. This 
adenoma is by definition well-circumscribed with a fibrous capsule (see left side, 
low magnification), and lacks features of malignancy (right side, higher 
magnification). Images courtesy of University of Massachusetts Medical School, 
Department of Pathology. 
Malignant epithelial neoplasms are termed carcinomas, i.e. 
adenocarcinoma (Figure 2), squamous cell carcinoma, basal cell 
carcinoma, small cell carcinoma etc. 
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Figure 2a, b. Breast Adenocarcinoma. (a) This is an invasive ductal 
adenocarcinoma of the breast (low magnification). (b) Invasion is seen by the 
tumor infiltration of the adjacent benign fat (higher magnification). (Compare 
normal glands of the fibroadenoma in Figure 1 to the disorganized cancerous 
glands). Images courtesy of University of Massachusetts Medical School, 
Department of Pathology. 
Sarcomas- derive from mesenchymal tissue: This is includes 
connective tissue. Examples of malignancies include: 
Osteosarcoma  Bone 
Chondrosarcoma  Cartilage 
Fibrosarcoma (Figure 3a,b)  Connective tissue 
Leiomyosarcoma  Smooth muscle 
Rhabdomyosarcoma  Striated muscle 
Angiosarcoma  Blood vessel 
 
Figure 3a, b. (a) Fibrosarcoma (low magnification) is a malignant tumor of 
immature proliferating fibroblasts characterized by spindled-cells in fascicles. 
(b) Higher magnification shows multiple mitotic figures (arrows). Images 
courtesy of University of Massachusetts Medical School, Department of 
Pathology Department. 
Hematopoietic cancers are also derived from mesenchymal tissue: 
Tumors of the blood or hematopoietic derivatives 
Lymphoma: Refers to hematopoietic mass within the soft tissue, 
organs, or lymph nodes (Figure 4) 
Leukemia: Refers to hematopoietic malignancies of blood or fluid 
spaces 
 
Figure 4a, b. Diffuse Large B cell lymphoma. (a) Low magnification of a skin 
biopsy shows malignant lymphocytes (blue) within the dermis (pink). (b) 
Higher magnification shows large crowded single lymphocytic cells with scant 
cytoplasm and high mitotic count. Images courtesy of University of 
Massachusetts Medical School, Department of Pathology. 
Neural crest (ectoderm) derived cancers: 
Tumors of the brain and spinal cord (Central Nervous System): 
- Glioblastoma: High grade malignant brain tumor arising from 
astrocytes 
Tumors of the melanocytes in the basal layer of the skin 
- Benign melonocytic neoplasm (nevus): a mole or birthmark 
- Malignant melanocytic neoplasm: Melanoma (Figure 5)  
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-  
Figure 5. Malignant melanoma. This shows nested proliferation of malignant 
melanoncytic cells in the dermis (low magnification). Image courtesy of 
University of Massachusetts Medical School, Department of Pathology 
Department. 
Identifying Features of Malignancy 
A neoplasm is considered to be malignant when pathologic examination 
shows characteristic features which include: 
- Disordered growth pattern: Back-to-back glands or irregular 
arrangement of cells (Figure 6) 
 
Figure 6. Adenocarcinoma with back-to-back glands (20x). Image courtesy 
of University of Massachusetts Medical School, Department of Pathology. 
- Cellular atypia. Cells have increased nuclear size relative to 
cytoplasm (nuclear-to-cytoplasmic ratio or N:C ratio), prominent 
nucleoli or darker appearing nuclei due to increased DNA content  
(hyperchromatic), pleomorphism (variation in size and shape) 
(Figure 7). 
 
Figure 7. Pleomorphism is defined as variations in size and shape of cells 
(x40). Notice the increased nuclear –to –cytoplasmic ratio (N:C ratio), 
hyperchromatic nuclei and prominent nuclei of the malignant cells. Image 
courtesy of University of Massachusetts Medical School, Department of 
Pathology. 
- Increased mitotic activity or atypical mitotic figures. While increased 
mitotic figures are not in itself indicative of malignancy, often with 
increased cell turn-over there are atypical mitotic figures (Figure 4) 
and/or necrosis (Figure 8). 
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Figure 8. Breast carcinoma with necrosis (long arrow) and calcifications 
(short arrow). Image courtesy of University of Massachusetts Medical 
School, Department of Pathology. 
- Demonstrates invasion: for example, invasion through basement 
membrane into submucosa or deeper in gastrointestinal sites 
(Figure 9), invasion of a capsule such as in endocrine organs (i.e. 
thyroid or adrenal)  or evidence of infiltration of stroma or adipose 
tissue (Figures 2a, b; 9) or into lymphatics (Figure 10). 
 
Figure 9. Gallbladder with invasive adenocarcinoma through the muscle 
and deep into the submucosa (4x). Image courtesy of University of 
Massachusetts Medical School, Department of Pathology. 
 
Figure 10a, b. (a) Lymphatic invasion (40x). (b) The picture on the right 
uses a special stain to highlight the lymphatic channels and clearly shows 
that malignant glands are within the lumens (40x). University of 
Massachusetts Medical School, Department of Pathology. 
- Loss of polarity – for example, in reference to columnar neoplasms, 
the nucleus is at the base on top of the basement membrane (Figure 
11a). In a malignant process the cells begin to crowd and lose this 
orderly process, so that nuclei can be seen stratified towards the 
apical surface (Figure 11b). 
 
Figure 11 a, b. Loss of polarity. Compare basally located nuclei with 
apical mucin in normal glandular epithelium (a) to nuclear stratification in 
malignant gland (b) (x40). University of Massachusetts Medical School, 
Department of Pathology. 
Precursors of Cancer 
Cancers frequently develop from precursor lesions. It is the early detection 
of these precursor lesions which is the basis for screening tests (i.e. pap 
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smears for cervical cancer, colonoscopy for colon cancer etc.). 
Metaplasia 
Metaplasia is the replacement of one type of epithelium by another. This 
process is thought to be a response to chronic irritation. In most cases 
metaplasia is a reactive response and considered benign. In smokers with 
chronic smoke irritation, the ciliated epithelium within the respiratory 
airway may undergo squamous metaplasia with loss of cilia necessary to 
evacuate accumulating mucus. In contrast, chronic acid reflux irritation at 
the gastro-esophageal junction (GE junction) can induce the flat 
esophageal squamous mucosa to undergo metaplastic change and 
become gland-forming intestinal mucosa. This gland formation is known 
as Barrett’s esophagus (Figure 12a and b) and is a known precursor for 
the development of esophageal adenocarcinoma in the distal esophagus. 
 
 
 
Figure 12a, b. Barrett’s metaplasia. (a) This is a biopsy of the gastro-esophageal 
junction (GE junction) showing esophageal squamous epithelium (left) and 
metaplastic Barrett’s esophagus (right) (10x). (b) Compare the normal pink 
columnar gastric mucosa (right) the adjacent Barrett’s esophagus which shows a 
bluish tint and prominent mucinous vacuoles reminiscent of colonic glandular 
epithelium (20x). 
 
Dysplasia 
This is the abnormal growth of cells. In contrast to hyperplasia which is the 
overgrowth of normal cells, dysplastic cells tend to have variation in both 
size and shape (pleomorphism), shows cellular crowding, atypia and, over 
time, may progresses to cancer. This progression to cancer may be over 
the course of many years. 
Dysplasia can be considered low grade or high grade depending on 
nuclear features. Low grade dysplasia indicates that there are atypical 
cells that involve only the area closest to the basement membrane. In 
some locations such as the cervix, low grade dysplasia may regress back 
to normal. Alternatively, in most organs this may remain low grade 
dysplasia or progress to high grade dysplasia. High grade dysplasia 
usually has large cells crowding and stratifying toward the apical surface 
away from the basement membrane. High grade dysplasia is always 
worrisome for impending progression to cancer and requires clinical 
management (Figure 13a and b). 
 
Figure 13a, b. This is another biopsy of the GE junction (a) (10x). The esophageal 
squamous mucosa is on the right transitioning into low grade dysplasia in this 
patient that has Barrett’s esophagus (not illustrated in this image). (b) These 
glands demonstrate high grade dysplasia. Note how the crowded cells are 
stratified rather than remaining near the basement membrane, the nuclei appear 
hyperchromatic (darker) with nuclear enlargement (20x). Compare to Figure 14. 
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Figure 14: Invasive esophageal adenocarcinoma with surface ulceration. 
University of Massachusetts Medical School, Department of Pathology. 
 
Carcinoma-in-situ 
In-situ is a Latin phrase meaning “in position”. The use of this term means 
that the cells fulfill all other criteria for malignancy, except they have not 
invaded the basement membrane (yet). These cells can shed off the 
surface, and this fact can be exploited by simple screening tests such as 
urinalysis and cervical pap testing. These cells must involve the full 
thickness of the epithelium, and if left untreated may progress to invade 
through the basement membrane becoming invasive cancer (Figure 14). 
As this is considered a precursor to cancer, clinical treatment is required. 
Conclusion 
Pathology uses microscopy to diagnosis human diseases. In the case of 
cancer, cell morphology reflects underlying genetic damage to what was 
once a normal cell. As genetic alterations accumulate, cell morphology 
becomes increasingly bizarre. The changes described in this chapter – 
alterations in polarity or nucleus to cytoplasmic ratio, emergence of 
prominent nucleoli, increased mitotic figures, and pleomorphism – all are 
ultimately due to mutations. Additional cell abnormalities lead to the ability 
of a neoplasm to invade tissues or metastasize to distant locations. 
Pathologic review of tissue specimens is able to distinguish between 
aberrant growth of tissue confined to appropriate anatomic boundaries in 
the region of the organ of origin and metastatic spread. Increasingly 
pathologists are also using molecular studies of tissue to help guide 
diagnosis of cancer. Ultimately a pathologist uses her tools to translate the 
underlying genetic damage of cells into a clinical diagnosis. 
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Thought Questions 
1. A 47 year old woman has suspicious calcifications found in her left 
breast on mammogram. A biopsy of the area shows ductal carcinoma 
in situ. What can you tell her about how this differs from invasive ductal 
carcinoma? If untreated, will it become an invasive cancer? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expert Answer 
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2. Understanding the pathogenesis of cancers has lead to better 
detection methods such as pap smear screening with HPV testing. 
Consider how we have applied this information to prevent cervical 
cancer. Can this technology be applied to other cancers, and why? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expert Answer 
Glossary 
Angiogenesis- Formation of new blood vessels 
Apoptosis- genetically determined programmed cell death 
Barrett’s esophagus- Intestinal metaplasia of the distal esophagus 
Grade (of a malignancy)– Numerical assessment for differentiation; three 
tiers: low grade (grade 1 of 3) appears similar to normal, moderate grade 
(grade 2 of 3) and high grade (grade 3 of 3). 
Hyperplasia- Increase in number of normal cells in a tissue  
Metastases- Tumors growing in an organ remote from the primary tumor 
MDM2 – a protein which, when bound to p53 down regulates the p53 
tumor suppressor function, thereby permitting cell division 
Pathology- The study of disease 
Prefixes:  
Adeno- glands 
Astro- deriving from astrocytes, non neurons in centrala nervous 
tissue 
Chondro- cartilage 
Glio- arising from glial cells, also non-neuron cells in central 
nervous system 
Leio- smooth muscle 
Myo- muscle 
Osteo- bones 
Rhabdo-derived from skeletal muscle 
Sarc- “flesh”, refers to soft tissue 
Stroma- Connective tissue framework of an anatomic structure, usually an 
organ 
Tumor- Swelling (not necessarily neoplastic) 
Well differentiated- Resembles normal tissue 
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